Castle biosciences publishes decisiondx®-melanoma study on the validation of the i31-gep slnb artificial intelligence algorithm

Friendswood, texas--(business wire)---- $cstl #decisiondxmelanoma--castle announced the publication of a study validating performance of the i31-slnb algorithm to determine sentinel lymph node biopsy positivity risk.
CSTL Ratings Summary
CSTL Quant Ranking